The Latest Breaking News from INVA

3 Bargain-Cheap Small Caps Worth a Second Look

Three low P/E small-cap stocks offer distinct catalysts and upside potential as investors look ahead to a broader market rally

MarketBeat · Apr 9

Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out

Significant updates from the FDA toward the end of 2025 have rallied investor interest in Axsome and Innoviva, two high-potential biotech names for 2026.

MarketBeat · Jan 8

3 Small-Cap Biotech Stocks With Game-Changing Potential

The biotech industry offers a compelling investment opportunity due to its potential for disruptive innovations and high growth. Thus, investing in fundamentally strong small-cap stocks Esperion Therapeutics (ESPR), Innoviva, Inc. (INVA), and SIGA Technologies (SIGA) could be significantly rewarding. Read on….

StockNews.com · Oct 17, 2024

3 Biotech Stocks with Potential Gains - Watch or Buy?

The biotech industry’s growth prospects look promising due to advanced technologies like AI, the growing popularity of tailored treatments, a rise in chronic diseases, and higher R&D spending. Let's analyze the investment prospects of biotech stocks Innoviva (INVA), Organogenesis Holdings (ORGO), and Compugen (CGEN). Read more.

StockNews.com · Apr 15, 2024

3 Biotech Stocks to Jumpstart Your Portfolio Gains

The biotech industry is poised for robust growth due to increasing demand for personalized treatments, rising prevalence of chronic diseases, heightened investments in R&D, and advancements in technology. Therefore, investors could consider buying fundamentally strong biotech stocks Innoviva (INVA), ANI Pharmaceuticals (ANIP), and United Therapeutics (UTHR). Read more.

StockNews.com · Mar 14, 2024

3 Biotech Stocks to Buy for Profits Beyond 2024

The biotech industry is expected to deliver steady returns amid rising medical needs and increased research and development investment. Therefore, fundamentally strong biotech stocks Illumina (ILMN), Innoviva (INVA) and Puma Biotechnology (PBYI) might be ideal additions to your portfolio. Read on.

StockNews.com · Feb 29, 2024

Dominate the Market With 3 Biotech Stocks

The biotech industry’s growth prospects look promising due to considerable investments in research and development (R&D), an innovative drugs pipeline, government initiatives, the growing popularity of personalized medicine, drug approvals, expanding healthcare needs, etc. Amid this backdrop, investors could consider buying fundamentally strong biotech stocks Innoviva (INVA), Foghorn Therapeutics (FHTX),…

StockNews.com · Feb 16, 2024

3 Lucrative Biotech Stock Buys for Success

The development of orphan medications, innovative biotech equipment, personalized medicine, and strong government support are all contributing to the biotech industry's upward trajectory. Thus, lucrative biotech stocks Vertex Pharmaceuticals (VRTX), Innoviva (INVA), and Organogenesis Holdings (ORGO) could be ideal additions to your portfolio right now. Read more….

StockNews.com · Jan 25, 2024

2024 Buys: Top Biotech Stock Trio to Consider

The biotechnology industry is experiencing significant growth, fueled by rising technological innovations and government support. Therefore, it could be wise to consider fundamentally strong biotech stocks Genfit (GNFT), Equillium (EQ), and Innoviva (INVA) for 2024. Read more.

StockNews.com · Dec 27, 2023

Analyzing the Bullish Opportunities of 3 Biotech Stocks

The biotech industry is well-positioned for solid growth due to rising demand for quality treatments and therapies, a rapidly aging population, adoption of technologies like AI and government initiatives. To leverage these trends, consider investing in quality biotech stocks Innoviva (INVA), Puma Biotechnology (PBYI), and Shionogi (SGIOY). Keep reading….

StockNews.com · Dec 11, 2023